Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News on Pharma

Will These 3 Biotech Stocks Make Gains in 2024?

In the swiftly progressing arena of biotechnology, technological advancements, increasing merger and acquisition maneuvers, and developing product pipelines are driving significant expansion in this sector. The sector's strong potential is further reinforced by a steady demand, ensuring its sustenance. Given this backdrop, let’s analyze whether or not biotech stocks Illumina…

3 Biotech Stock Gems Bursting With Buy Opportunities

3 Biotech Stock Gems Bursting With Buy Opportunities

The biotech industry is well poised to flourish, buoyed by its commitment to innovation and potential for groundbreaking discoveries. Thus, investing in the shares of three fundamentally solid biotech companies, Foghorn Therapeutics (FHTX), Jazz Pharmaceuticals (JAZZ), and Gilead Sciences (GILD), might be prudent. Continue reading….

Buy, Hold, or Sell? Analyzing 3 Biotech Stocks Investors Are Watching

Buy, Hold, or Sell? Analyzing 3 Biotech Stocks Investors Are Watching

Amid the use of advanced technologies, personalized medicines, demand for quality treatments and therapies, and an aging population, the biotech industry appears to be on a steady path for expansion. Given this backdrop, let’s analyze the fundamentals of Biogen (BIIB), BioNTech (BNTX), and Kura (KURA) to determine which of these…

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

More than 10,000 spared GP visit under new trials

A series of trials operating across the nation has allowed 10,000 women to get a new supply of the pill or receive treatment for uncomplicated infections.

Johnson & Johnson (JNJ): Analyzing Signals Before Quarterly Earnings

Pharmaceutical powerhouse Johnson & Johnson (JNJ) is proactively driving innovation throughout the healthcare spectrum, thanks to its strong focus on innovative medicines and MedTech solutions. However, with the company’s fiscal fourth-quarter earnings on the horizon, could the stock be a wise portfolio addition? Keep reading to find out….

NHS drug shortages are partly a political failure

Letters: Britain is pushing for patent changes in India that could increase the cost of generic drugs, writes Tim Bierley; plus letters from readers on the human cost of shortages

The Guardian - UK

3 Pharma Stocks to Watch in 2024 for Later Gains

The pharmaceutical industry looks well-positioned for long-term growth. Hence, pharma stocks Procaps Group (PROC), Organon (OGN) and Amphastar (AMPH) might be ideal additions to your watchlists for later gains. Read on.

inkl

Read news from The Economist, FT, and more,
with one subscription

What’s the Best 2024 Pharma Stock Buy Among These 3 Stocks?

What’s the Best 2024 Pharma Stock Buy Among These 3 Stocks?

The pharma industry's potential for sustained growth is reinforced by an aging population, escalating healthcare demands, and the increase in chronic diseases. Therefore, let’s assess the fundamentals of pharma stocks Eli Lilly (LLY), Johnson & Johnson (JNJ), and Abbvie (ABBV) to determine the most promising choice for the current year….

2024 Will Be a Good Year for the Pharma Industry: The Kiplinger Letter

2024 Will Be a Good Year for the Pharma Industry: The Kiplinger Letter

Five pharma companies will have sales that exceed $50 billion this year.

Generic drugs in the US are too cheap to be sustainable, experts say

Generic drugs in the US are too cheap to be sustainable, experts say

Non-brand-name drugs are one inexpensive part of the healthcare system but they’re driving some manufacturers out of business

The Guardian - US

Union Cabinet approves memoranda on health products with Netherlands, Dominican Republic, Ecuador

Union Cabinet approves memoranda on health products with Netherlands, Dominican Republic, Ecuador

“The Union Cabinet on January 18 approved separate memorandum with the Netherlands, Dominican Republic and Ecuador on cooperation in the field of medical products regulation,” an official statement said.

3 A-Rated Medical Stocks to Watch and Buy

3 A-Rated Medical Stocks to Watch and Buy

The medical industry is set for significant growth due to technological advances, increased demand for medicines due to an aging population, escalating healthcare costs, and the rising need for quality healthcare. Therefore, it could be wise to buy fundamentally strong medical stocks GSK (GSK), National HealthCare (NHC), and MiMedx Group…

What to know about January's annual drug price hikes

What to know about January's annual drug price hikes

Spoiler: There are some decreases this year, too. Here's an overview of the changing prices and what to make of them.

Exclusive: AAP govt procured drugs from 2 blacklisted pharma firms with many failed quality tests

Exclusive: AAP govt procured drugs from 2 blacklisted pharma firms with many failed quality tests

Six drugs from six pharma firms have fuelled a tussle between the Centre and the Delhi government, with both sides trying to blame each other for substandard medicines making their way to the capital’s government hospitals.

Get all your
news in one place.

100’s of premium titles.
One news app.

The Guardian - UK

UK sets up critical imports council to protect vital supplies

Group will tackle potential restrictions to items such as medicine amid geopolitical and climate threats

International Business Times UK

NHS Medicine Shortage Raises Concerns Over Patient Safety

There is a notable 100 per cent surge in medicine shortages compared to January 2022 as seen in the deteriorating health of patients across the UK.

3 Pharma Stocks for January 2024 Profits

The pharmaceutical industry is thriving, fueled by steady demand for drugs, cost-efficient alternative discoveries, and rapid technological innovations. Hence, fundamentally strong pharma stocks Novo Nordisk (NVO), Eton Pharmaceuticals (ETON), and Pacira BioSciences (PCRX) might be profitable buys now. Read on….

Evening Standard

Why is there a medicine shortage in the UK? Pharmacists urge political parties to prioritise issue

34 and 11 serious shortage protocols (SSPs) were issued in 2022 and 2023 respectively

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Synthetic opioids could fuel ‘second wave’ of UK drug deaths crisis, experts warn

Government urged to act as experts sound the alarm on nitazenes, with 54 deaths in past six months likely ‘tip of the iceberg’

State Economics — Spotlight on New England: The Kiplinger Letter

After a better-than-expected 2023, New England states will see only modest employment growth in 2024.

Are These 4 Biotech Stocks Worth Buying in 2024?

The need for innovative healthcare solutions, personalized medicines and treatments, and the use of advanced technologies will propel the biotech industry forward. Amid this backdrop, let’s explore the investment potential of biotech stocks TG Therapeutics (TGTX), Galapagos (GLPG), BioMarin Pharmaceutical (BMRN), and United Therapeutics (UTHR).

Bayer undeterred by setback, forges ahead with US expansion

Bayer remains undeterred by setbacks as they forge ahead with plans to expand in the US market, showing resilience and determination in the face of challenges.

Merck Hooks Harpoon Therapeutics in 0M Acquisition Spree!

Merck sets sail into new therapeutic waters with the 0 million acquisition of Harpoon Therapeutics, harnessing the power of innovation to navigate treat...

Health Ministry notifies revised Pharma manufacturing rules under schedule M to ensure quality control

Revised Schedule M of Drugs and Cosmetics Rules, 1945 notified by Union Health Ministry to ensure robust quality control for pharma and biopharmaceutical products.

FDA allowing drug imports from Canada to lower prescription costs

Get the latest on the FDA's decision to allow Florida to import medications from Canada, potentially reducing prescription costs for Americans. Learn about...

1 … 34 35 36 37

People

Dipanjan BanchurSince

Sristi Suman JayaswalThe

Saurabh Bharadwaj

Vinai Kumar Saxena

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

World Health Organization

Johnson & Johnson (

Health Ministry

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

325,149 stories

127,745 stories

New South Wales

Dominican Republic

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play